OBA-PHARMA ApS: Financial statements 2020
CVR: 19995607
Source: annual report 2020, Danish Business Authority
01/10/2019 – 30/09/2020
OBA-PHARMA ApS (CVR 19995607) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,119,532 and a net result of DKK 865,029 compared with DKK 1,803,661 the year before. That is a decrease of 50.3% compared with the year before. Equity in the 2020 report amounted to DKK 1,167,112. The solvency ratio was 36.4%.
- Gross Profit
- DKK 1,119,532
- Profit/Loss
- DKK 865,029
- Equity
- DKK 1,167,112
- Total Assets
- DKK 3,204,849
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.1 mio. | 865 t. | 1.2 mio. | 0 |
| 2019 | - | 2.3 mio. | 1.8 mio. | 2.3 mio. | - |
| 2018 | - | 2.5 mio. | 2.1 mio. | 6.5 mio. | - |
| 2017 | - | 2.8 mio. | 2.2 mio. | 4.4 mio. | - |
| 2016 | - | 2.8 mio. | 2.2 mio. | 2.8 mio. | - |
Official annual report
How creditworthy is OBA-PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
OBA-PHARMA ApS has published its annual report for 2019. Gross profit came to DKK 2,252,532, and the net result was DKK 1,803,661.
About OBA-PHARMA ApS
OBA-PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PBH 25.376 ApS. The management consists of Malene Dybdahl Birch. The company is owned by LEV-VEL ApS and NLDB Holding ApS. The company has 0 employees (2000). In 2024, the company reported a gross profit of DKK 3,402,201 and a net result of DKK 2,670,973 compared with DKK 2,073,440 the year before. Equity in the 2024 report amounted to DKK 674,251.